↓ Skip to main content

Cochrane Database of Systematic Reviews

Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children

Overview of attention for article published in Cochrane database of systematic reviews, April 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter
9 tweeters
wikipedia
1 Wikipedia page
f1000
1 research highlight platform

Citations

dimensions_citation
170 Dimensions

Readers on

mendeley
253 Mendeley
Title
Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children
Published in
Cochrane database of systematic reviews, April 2013
DOI 10.1002/14651858.cd006602.pub4
Pubmed ID
Authors

Tea Andabaka, Jason W Nickerson, Maria Ximena Rojas-Reyes, Juan David Rueda, Vesna Bacic Vrca, Bruno Barsic

Abstract

Respiratory syncytial virus (RSV) is one of the most important viral pathogens causing acute respiratory infections in children. It results in about 3.4 million hospitalisations annually in children under five. Palivizumab is an anti-RSV monoclonal antibody, administered intramuscularly at a dose of 15 mg/kg once every 30 days. The efficacy and safety of palivizumab has been evaluated in multicentre, randomised controlled trials (RCTs) and a large number of economic evaluations (EEs) have tested its cost-effectiveness.

Twitter Demographics

The data shown below were collected from the profiles of 9 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 253 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 <1%
Canada 2 <1%
France 1 <1%
South Africa 1 <1%
Spain 1 <1%
United States 1 <1%
Unknown 245 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 48 19%
Researcher 36 14%
Student > Ph. D. Student 31 12%
Student > Bachelor 30 12%
Student > Postgraduate 22 9%
Other 49 19%
Unknown 37 15%
Readers by discipline Count As %
Medicine and Dentistry 118 47%
Nursing and Health Professions 20 8%
Social Sciences 13 5%
Pharmacology, Toxicology and Pharmaceutical Science 10 4%
Agricultural and Biological Sciences 9 4%
Other 34 13%
Unknown 49 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 July 2020.
All research outputs
#2,501,769
of 16,699,900 outputs
Outputs from Cochrane database of systematic reviews
#5,130
of 11,574 outputs
Outputs of similar age
#23,754
of 158,795 outputs
Outputs of similar age from Cochrane database of systematic reviews
#44
of 122 outputs
Altmetric has tracked 16,699,900 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,574 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.4. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 158,795 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 122 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.